ABBV - If You Like AbbVie You Should Be Buying Allergan
By now, just about everyone has heard about AbbVie’s (ABBV) bid to acquire Allergan (AGN). If you haven’t already, I encourage you to view the investor presentation. For a deeper look, also consider reading my previous article, Merger Math: Allergan + AbbVie. I also recommend reading Dividend Sensei’s 3 Things Investors Need to Know About AbbVie’s Future, Chuck Carnevale’s AbbVie Has it All, and David Zanoni’s AbbVie SWOT Analysis, as well as the associated comment threads for reasons why this is a compelling investment. It’s not